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Abstract
Zn plays an important role in maintaining the anti-oxidant status within the heart and helps to counter the acute redox stress that occurs during
myocardial ischaemia and reperfusion. Individuals with low Zn levels are at greater risk of developing an acute myocardial infarction; however,
the impact of this on the extent of myocardial injury is unknown. The present study aimed to compare the effects of dietary Zn depletion with
in vitro removal of Zn (N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN)) on the outcome of acute myocardial infarction and
vascular function. Male Sprague–Dawley rats were fed either a Zn-adequate (35mg Zn/kg diet) or Zn-deficient (<1mg Zn/kg diet) diet for
2 weeks before heart isolation. Perfused hearts were subjected to a 30min ischaemia/2 h reperfusion (I/R) protocol, during which time ventricular
arrhythmias were recorded and after which infarct size was measured, along with markers of anti-oxidant status. In separate experiments, hearts
were challenged with the Zn chelator TPEN (10 µM) before ischaemia onset. Both dietary and TPEN-induced Zn depletion significantly extended
infarct size; dietary Zn depletion was associated with reduced total cardiac glutathione (GSH) levels, while TPEN decreased cardiac superoxide
dismutase 1 levels. TPEN, but not dietary Zn depletion, also suppressed ventricular arrhythmias and depressed vascular responses to nitric oxide.
These findings demonstrate that both modes of Zn depletion worsen the outcome from I/R but through different mechanisms. Dietary Zn
deficiency, resulting in reduced cardiac GSH, is the most appropriate model for determining the role of endogenous Zn in I/R injury.
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Zn is the second most widely distributed trace element in the
body after Fe(1) and the most abundant intracellular trace ele-
ment(2). The storage capacity for Zn is low; and therefore,
healthy Zn levels are maintained through dietary intake, with
around 2–3mg Zn/d being required. However, the prevalence
of nutritional Zn deficiency is estimated to be high, and current
estimates suggest that over two billion people in the developing
world have insufficient dietary Zn intake(3). Moreover, in
industrialised countries, elderly people represent a high-risk
group as it is known that Zn intake decreases with age, with
only approximately 40% of individuals aged 71 years or older
having an adequate Zn intake(4).
Zn is important in cardiovascular physiology as it acts as an
indirect antioxidant, serves to stabilise membrane structure
and regulates metallothionein levels (reviewed in Xu &
Zhou(5)). The antioxidant role of Zn is achieved through the
requirement of Zn for superoxide dismutase (SOD)1 activity,
its protection of thiols and its ability to inhibit the Fenton
reaction (which converts H2O2 to hydroxyl radicals) by com-
peting with Fe(5). Zn is also a physiological suppressor of
apoptosis(6). Given this essential role in maintaining cellular
homoeostasis, disruptions in cellular Zn levels (or alterations
in intracellular signalling events involving Zn) could result in a
loss of antioxidant capacity of tissues and may induce, or at
least facilitate, the induction of apoptotic cell death. Conse-
quently, disruption of Zn homoeostasis is likely to play an
important role in CVD.
Zn plays a protective role in the four key events that per-
petuate myocardial injury following acute myocardial ischaemia
and reperfusion (IR injury); studies have shown that cardiac Zn
Abbreviations: AAR, area at risk; BW, body weight; CAO, coronary artery occlusion; CPP, coronary perfusion pressure; Cu/Zn-SOD, copper/zinc superoxide
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counters the acute redox stress that occurs in cardiomyocytes
upon reperfusion, inhibits inflammatory processes that con-
tribute to delayed injury, contributes positively to tissue healing
and assists in maintaining cardiac stem cells involved in tissue
repair (reviewed in Lee et al.(7)). Cardiac and plasma Zn levels
are severely depleted in patients post-myocardial infarction, the
extent of depletion correlating with myocardial infarction out-
come(8) and with the levels of enzyme markers (lactate dehy-
drogenase and creatine kinase) of the extent of myocardial
injury and the severity of arrhythmia(9), leading to the proposal
that Zn supplementation given at the time of reperfusion may
represent a cardioprotective approach. Indeed, studies have
shown that administration of Zn pyrithione at the time of
reperfusion in isolated hearts can ameliorate reperfusion-
induced injury via the reperfusion injury salvage kinase path-
way(10), improve post-reperfusion contractile recovery and
reduce reperfusion-induced ventricular fibrillation (VF)(11) and,
in hyperlipidaemic hearts, restore the infarct reducing effect of
preconditioning(12), while chronic Zn supplementation before
I/R reduces infarct size and increases cardiac glutathione (GSH)
content(13). Conversely, studies looking at acute Zn depletion,
using the Zn chelator TPEN (N,N,N′,N′-tetrakis(2-pyr-
idinylmethyl)-1,2-ethanediamine), demonstrate a worsening of
infarct size (reviewed in Lee et al.(7)) but reduced arrhythmia
severity(14,15). However, it is debateable how closely these
experimental conditions mimic the conditions imposed by
dietary Zn deficiency within the heart. Considering the pre-
valence of sub-optimal Zn intake in various populations, and
the potentially detrimental impact this may have on the extent
of cardiac injury sustained during an acute myocardial infarc-
tion, it is surprising that there is in fact a paucity of data on this
topic. Beyond two experimental dietary Zn-depletion studies
that show increased cardiac lipid peroxide levels (but no impact
on in infarct size) following sustained coronary occlusion
without reperfusion(16), and a worsening of post-reperfusion
recovery of contractile dysfunction associated with alterations in
cardiac tissue anti-oxidant enzymes(17), very little is known.
In the vasculature, in vivo Zn deficiency is associated with
an increased risk of atherogenesis (reviewed in Beattie &
Kwun(18) and Choi et al.(19)) due to a heightened pro-
inflammatory status(20), and experimental studies have
shown that Zn deficiency during fetal development(21) and
growth(22) in rats induces changes in endothelial function that
may contribute to the programming for the development of the
hypertension observed in these animals. Dietary Zn deficiency
also increases apoptosis in large arteries through a mechanism
involving oxidative stress-induced induction of pro-apoptotic
proteins(23), while in vitro studies show that cellular Zn
depletion results in a reduced endothelial cell barrier func-
tion(24) and an increased vascular smooth muscle cell pro-
liferation(25). However, to date very little evidence exists as to
what functional consequences these changes have on vascular
contraction and relaxation.
The aim of the current study, therefore, was to explore the
impact and underlying mechanisms of dietary Zn deficiency on
the outcome (myocardial infarct size and incidence of arrhyth-
mias) of an acute I/R insult and on vascular function, in com-
parison with acute TPEN-induced Zn deficiency.
Methods
Animals
Male Sprague–Dawley rats (200–250 g) were purchased from
Harlan UK and housed in the University of Aberdeen Medical
Research Facility. All animals were maintained at a temperature
of 21± 2°C and humidity of 45± 10%, with a 12 h light–12 h
dark cycle and brought to the Biological Services Unit at the
Robert Gordon University on a weekly basis and allowed to
acclimatise before commencing the experimental protocol. All
animals, except for those receiving a Zn-deficient (ZD) diet and
their pair-fed (PF) counterparts, were housed using standard
caging and allowed free access to both food and tap water. Due
to the requirement to accurately assess food intake in the ZD
and PF rats, these animals were single housed in Zn-free cages
with grid flooring; any discomfort caused by the grid flooring
was minimised by the inclusion of Zn-free nesting tunnels/
inserts in the cage. These animals were also housed on a
reverse 12 h light–12 h dark cycle to allow for twice daily
feeding and measurement of food intake. All studies were
performed under an appropriate Project License authorised
under the UK Animals (Scientific Procedures) Act 1986. All
in vivo work is reported in accordance with the ARRIVE
guidelines(26). Group sizes were determined based upon power
calculations performed on previous studies using isolated per-
fused hearts. Animals were allocated to dietary intervention
groups based upon body weight (BW), so that PF and ZD
animals were of a similar weight at the start of the intervention
period. For the in vitro Zn-depletion study, hearts were ran-
domly assigned to control or TPEN groups.
Dietary intervention study
To determine the effects of acute Zn deficiency on the outcome
of I/R and vascular function, rats (ten per group) were ran-
domly allocated to a 14 d dietary intervention period of either a
Zn-adequate (ZA) diet (35mg Zn/kg diet) fed ad libitum or a
ZD (<1mg Zn/kg diet) diet provided twice daily to allow for
measurement of food intake. Both diets have been described
elsewhere(27) and were essentially based on the AIN-76A
recommendations. Since the consumption of a ZD diet results in
cyclical feeding behaviour and reduced weight gain, a further
group of ten rats was included as PF controls to determine the
impact of reduced weight gain, as opposed to Zn deficiency, on
any of the end points. Each of the rats was weight matched to a
ZD rat and fed the same quantity of ZA food consumed by the
ZD rat the previous day, and BW of all rats were monitored
daily. The study parameters and humane end points were set
such that, if a ZD rat failed to consume any food on any one
day, the PF rat would be provided with a specified quantity of
food; and if the BW of any ZD or PF animal varied by more than
30% from ZA controls fed ad libitum, it would be euthanised by
a schedule 1 method. To mitigate against this, the duration of
dietary Zn restriction and pair feeding was restricted to 14 d and
therefore neither intervention was required during the study. At
the end of the dietary intervention period, the rats were
euthanised as described below for the isolated heart experi-
ments. Before heart removal, blood was withdrawn by cardiac
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puncture for biochemical measurements, and tissues (liver,
white adipose tissue (WAT)) removed and weighed.
Coronary artery occlusion–reperfusion in the isolated heart
Rats were anaesthetised with intraperitoneal pentobarbital sodium
salt (100 mg/kg; Sigma Aldrich) and the heart rapidly removed and
arrested in ice-cold Kreb’s Henseleit buffer (KHB; 119mM NaCl,
4·7mM KCl, 1·18mM KH2PO4, 2·41mM MgSO4, 25mM NaHCO3,
2·52mM CaCl2 and 10·88mM glucose; pH 7·4). After the placement
of a ligature (6-0 silk suture (W812), Ethicon) around the left
coronary artery, the aorta was cannulated for retrograde perfusion
on a Langendorff apparatus (AD Instruments). Hearts were per-
fused with KHB at 37°C at a rate of 12ml/min and allowed to
stabilise for 15min before drug administration and subsequent
coronary occlusion. The coronary artery was occluded (CAO) by
tightening the ligature to induce regional ischaemia for 30min
after which the ligature was loosened and the myocardium
reperfused for 2 h. A surface electrocardiogram (ECG) was
recorded via electrodes placed on the right atrium and left ven-
tricle and coronary perfusion pressure (CPP) recorded via a
pressure transducer (MLT844 physiological pressure transducer;
AD Instruments) connected to the mounting head of the Lan-
gendorff apparatus. Ventricular arrhythmias that occurred during
the ischaemic period were analysed according to the Lambeth
Conventions(28). Heart rate (HR; calculated from the ECG), ECG,
and CPP were all monitored continuously throughout the
experimental period using a Power Lab data acquisition system
via an Animal Bio Amplifier and Bridge Amplifier, respectively,
and data subsequently analysed using Chart Software (all equip-
ment and software from AD Instruments). Any hearts that
developed spontaneous arrhythmias before CAO were excluded
from the study. Hearts from rats included in the dietary inter-
vention study were used to determine the effect of acute dietary
Zn depletion on the outcome or I/R. To determine the impact of
acute in vitro Zn depletion, either vehicle (0·01% dimethyl sulf-
oxide (DMSO); n 10) or TPEN (10 µM; concentration chosen based
on previously published work in isolated heart studies(14,29)) was
infused (at a rate of 100 µl/min) into isolated hearts via the aortic
cannula, starting 5min before ischaemia and terminating imme-
diately before CAO.
Histological measurement of infarct size
Following completion of the I/R protocol, the ligature around
the coronary artery was retied and Evans blue dye (2ml; 0·5% w/
v) perfused through the heart to delineate the area at risk (AAR).
Hearts were then removed and stored at –20°C before infarct size
determination. Frozen hearts were sliced into 2–3mm slices from
the apex to the base and allowed to defrost at room temperature.
Myocardial tissue slices were then incubated in 1% triphenylte-
trazonium chloride (Sigma Aldrich) in PBS for 15min at 37°C to
determine infarct size. Sections were then fixed in 10% buffered
formal saline for 1 h and imaged using an EOS 1100D digital SLR
camera (Canon Inc.) attached to a Leica S4E stereomicroscope
(Leica Microsystems Ltd). Left ventricular area, AAR and infarct
size were determined using computerised planimetry (ImageJ
software; National Institute of Health). AAR was expressed as a
percentage of total left ventricular area, and infarct size was
expressed as a percentage of AAR.
Isometric myography
Once hearts were mounted on the Langendorff apparatus and in
the stabilisation period, the mesenteric arterial arcade was excised
and placed in ice-cold KHB. Third-order mesenteric arteries were
then dissected out, cleaned of perivascular fat and stored in KHB
overnight at 4°C. Vascular function was then assessed in isolated
mesenteric arteries mounted onto a two-channel wire myograph
(model 510A; Danish Myo Technology (DMT)) containing oxy-
genated (95% O2 and 5% CO2) KHB at 37°C. Vessels were
normalised to achieve a transmural pressure of 100mmHg using
the DMT normalisation software. Isometric tension was recorded
and displayed using a PowerLab and Chart Software (both AD
Instruments). The viability of the smooth muscle was tested via
the addition of an 80mM KCl solution. Following KHB washes, a
cumulative concentration response was carried out with the
thromboxane mimetic U46619 (9,11-dideoxy-11α,9α-epox-
ymethanoprostaglandin F2α; Tocris Bioscience). Vessels were
then pre-contracted with a submaximal concentration (EC80;
concentration producing 80 % of the maximum response) of
U46619 and cumulative concentration responses carried out with
either the endothelium-dependent vasodilator, methacholine
(MCh), or the endothelium-independent vasodilator, sodium
nitroprusside (SNP). Vessels from the dietary intervention groups
were used to determine the impact of in vivo Zn depletion on
vascular function. To determine the effect of acute in vitro Zn
deficiency on vascular function, either (0·01% DMSO) TPEN
(10 µM) or 2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic
acid (DTPA) (10 µM; extracellular Zn chelator) was added to the
myograph bath before performing cumulative concentration
responses to either MCh or SNP.
Myocardial copper/zinc superoxide dismutase activity
Copper/zinc superoxide dismutase (Cu/Zn-SOD) activity was
measured in cardiac tissue samples (representing both ischae-
mic and non-ischaemic tissue) from all experimental groups
using a Superoxide Dismutase Assay kit (catalogue number:
706002; Cayman Chemical). Briefly, cardiac tissue was homo-
genised in ice-cold 20mM HEPES buffer (pH 7·2) containing
1mM ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetra-
acetic acid (EGTA), 210mM mannitol and 70mM sucrose. The
resulting homogenate was then subjected to multiple cen-
trifugation steps to separate mitochondrial and cytosolic SOD,
the latter of which was retained for subsequent analysis. Fol-
lowing protein quantification, protein concentrations were
normalised to 0·5mg/ml in all samples and Cu/Zn-SOD activity
measured via the kit as per the manufacturer’s instructions.
Myocardial glutathione content
Total GSH content was measured in cardiac tissue using a
Glutathione Assay kit (catalogue number: 703002; Cayman
Chemical). Briefly, cardiac tissues (representing both ischaemic
and non-ischaemic tissues) were homogenised in ice-cold MES
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buffer (pH 6·0) containing 200mM 2-(N-morpholino) ethane-
sulphonic acid, 50mM phosphate and 1mM EDTA. The resulting
homogenate was then centrifuged at 10 000g for 15min at 4°C,
the supernatant removed and subsequently deproteinated via
the addition of MPA reagent (1·25 M metaphosphoric acid).
Samples containing MPA reagent were then centrifuged at
3000g for 2min at room temperature, the supernatant removed
and TEAM reagent (4 M triethanolamine) added before assaying
for GSH content as per the manufacturer’s instructions.
Myocardial caspase-3 activity
Caspase-3 activity in heart tissue was determined by measuring
conversion of the caspase-3 substrate N-acetyl-Asp-Glu-Val-Asp
p-nitroanilide (Ac-DEVD-Pna) to p-nitroaniline. Briefly, tissue
samples (representing both ischaemic and non-ischaemic tis-
sue) were homogenised in ice-cold HEPES buffer (25mM; pH
7·4) containing 5mM EDTA, 2mM dithiothreitol (DTT) and 0·1%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS) and centrifuged at 20 000 g for 30min at 4°C. The
supernatant (5 µl) was then incubated with 85 µl HEPES buffer
(50mM; pH 7·4, containing 1·0mM EDTA, 10mM DTT, 0·1%
CHAPS, 100mM NaCl and 10% glycerol) and 10 µl Ac-DEVD-
Pna (200 µM) at 37°C for 24 h; the concentration of the product
(p-nitroaniline) was read at 405 nm.
Myocardial and plasma zinc levels
Cardiac tissue Zn levels were measured using a Zn Assay kit
(catalogue number: MAK032; Sigma Aldrich). Samples were pre-
pared as for the Cu/Zn-SOD activity assay and protein con-
centrations were normalised to 0·5mg/ml. Zn was measured via
the kit as per the manufacturer’s instructions, with the omission of
the deproteination step to measure both free and protein-bound
Zn. For determination of circulating trace metal levels, plasma
samples were analysed using a Unicam Solaar 969 atomic
absorption spectrophotometer as described previously(30) and
lactate dehydrogenase and creatine kinase levels were determined
using a Konelab clinical analyser (Thermo Fisher Scientific).
Statistical analyses
All data are expressed as means and standard errors of the
mean, and significance determined as P< 0·05. For the acute Zn
deficiency study, the ZD groups were compared with the PF
group as the appropriate control to eliminate any impact of
reduced energy intake on the end points. The impact of
reduced energy intake on end points was determined by
comparing the PF group with the ZA group. A two-tailed Stu-
dent’s t test was used to compare baseline CPP/HR values in the
vehicle and TPEN-treated hearts and compare the effect of
TPEN on both CPP and HR. A one-way ANOVA and Dunnett’s
post hoc test were used to compare pre-occlusion and post-
occlusion CPP/HR values within experimental groups and a
repeated-measures ANOVA and Bonferroni post hoc test used to
compare post-occlusion CPP/HR between the vehicle and
TPEN groups. For the acute Zn deficiency study, a one-way
ANOVA and Dunnett’s post hoc test were used to compare the
baseline CPP/HR values in the ZA, PF and ZD experimental
groups and the pre-occlusion and post-occlusion CPP/HR
values within the same experimental groups. A two-way
ANOVA and Bonferroni post hoc test were used to compare
post-occlusion CPP/HR values between the ZA, PF and ZD
experimental groups. In both experimental studies, ventricular
arrhythmias were determined from the ECG trace and classified
according to the Lambeth Conventions (II)(28). The effect of
TPEN on the number of each type of ventricular premature beat
(VPB), that is, singles, salvos, ventricular tachycardia (VT) and
total VPB count was analysed using a two-way ANOVA and
Bonferroni post hoc test. The effect of TPEN on the incidence of
VT, reversible ventricular fibrillation (rVF) and irreversible VF/
mortality was analysed using a Fisher’s exact test. In the acute
Zn deficiency study, the impact of the dietary interventions on
the number of VPB and incidences of VT, rVF and mortality was
compared between groups using a two-way ANOVA and
Bonferroni post hoc test and Fisher’s exact test, respectively.
Non-linear regression (using GraphPad Prism) was used to
generate curves for all vascular data and to calculate and
compare pEC50 (log of the half-maximal concentration) values
for each group. Concentration responses between groups were
compared via a repeated-measures ANOVA and Bonferroni post
hoc test. Emax values (maximal relaxation as a percentage of
induced tone) were compared using either a t test (acute Zn
deficiency study) or a one-way ANOVA and Dunnett’s post hoc
test (in vivo Zn deficiency study). Similarly, food intake, BW,
heart weight:BW, AAR, infarct size, Cu/Zn-SOD activity, GSH
content, caspase-3 activity and plasma/cardiac Zn levels were
all compared using either a t test or a one-way ANOVA and
Dunnett’s post hoc test, where appropriate.
Results
Impact of dietary zinc depletion on physiological measures
Consumption of the ZD diet resulted in characteristic cyclical
feeding behaviour associated with acute Zn depletion in rats
in that food consumption reduced by approximately 50% every
2–3d; the PF rats were therefore subjected to the same cyclical
feeding (Fig. 1(a)). Consequently, Zn deficiency resulted in a
significantly reduced weight gain over the 14d period of inter-
vention compared with normal-fed ZA rats (Fig. 1(b)). PF rats
given a Zn adequate diet also exhibited a reduced weight gain but
to a lesser extent compared with the ZD rats. ZD rats had a higher
heart weight:BW ratio (Fig. 1(c)) and a lower WAT:BW ratio
(indicative of altered body fat composition; Fig. 1(d)). Plasma
analysis confirmed that circulating Zn levels in the ZD rats were
significantly lower than those in both ZA and PF rats (Fig. 1(e)),
while cardiac tissue Zn levels were similar across all groups (Fig. 1
(f)). All other plasma markers (Cu2+ , Ca2+ , lactate and creatine
kinase) were unchanged (online Supplementary Table S1).
Dietary zinc depletion and the outcome of myocardial
ischaemia–reperfusion
Dietary Zn deficiency caused a significant increase in infarct
size compared with the extent of damage seen in hearts from PF
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rats (Fig. 2(a); AAR 56 (SEM 2) and 48 (SEM 6)%, respectively);
infarct sizes in PF and ZA rats (AAR 43 (SEM 3)%) were not
significantly different. PF rats exhibited a marked increase in
cardiac caspase-3 activity compared with ZA rats, while ZD rats
exhibited similar myocardial caspase-3 activity to ZA rats (Fig. 2
(b)). Pair feeding had no impact on either GSH levels or Cu/Zn-
SOD activity, while in ZD rats there was a marked reduction
in GSH levels (Fig. 2(c)) but no change in Cu/Zn-SOD activity
(Fig. 2(d)). Arrhythmia analysis revealed that PF animals
exhibited a significantly fewer VPB occurring as salvos (2–3
consecutive VPB) and VT (four or more consecutive VPB; Fig. 3
(a)), although the incidence of VT and total VF was unaffected
(online Supplementary Table S2); the arrhythmia profile in ZD
rats was similar to that in PF rats. Baseline CPP (Fig. 3(b)) and
HR (Fig. 3(c)) were the same irrespective of dietary interven-
tion, and the ischaemia-induced rise in perfusion pressure was
similar in all groups but reached statistical significance only in
the ZD group.
Dietary zinc depletion and vascular function
Contractile responses to U46619 was unaffected by either pair
feeding or Zn deficiency (Table 1). Similarly, blood vessels from
both PF and ZD rats exhibited comparable endothelium-
dependent (MCh; Fig. 4(a)) and -independent (SNP; Fig. 4(b))
vasodilator responses, with no alterations in either Emax or
pEC50 (Table 1).
Acute in vitro zinc depletion and the outcome of
myocardial ischaemia–reperfusion
Perfusion with TPEN (10 µM) before the onset of CAO caused a
significant increase in infarct size compared with control hearts
(P< 0·05; Fig. 5(a)); AAR was similar in both groups (43 (SEM 3)
v. 45 (SEM 3)% of LV area in control and TPEN-treated hearts,
respectively). Treatment with TPEN did not induce any sig-
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Fig. 1. Physiological alterations in response to a zinc-deficient diet in rats. Zinc deficiency (ZD, ) resulted in a cyclical feeding pattern (a) that resulted in a slowed
rate of growth (b). Pair feeding (PF, ) of rats a zinc-adequate (ZA, ) diet also slowed growth but to a lesser extent. ZD also influenced heart weight (HW; c)
and white adipose tissue (WAT; d) to body weight (BW) ratios. The impact of the ZD diet compared with PF and ZA on cardiac tissue (e) and plasma (f) zinc levels is
also shown. (a–d) Values are means (n 10 per group), with standard errors of the mean represented by vertical bars. (e) and (f) Values are means (n 4 per group), with
standard errors of the mean represented by vertical bars. *P< 0·05 compared with PF control animals. ppm, Parts per million.
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of I/R itself causes a reduction in both GSH levels (Fig. 5(c)) and
Cu/Zn-SOD activity (Fig. 5(d)) when compared with sham hearts,
whereas I/R did not alter caspase-3 activity (Fig. 5(e)). There was
no impact of TPEN treatment on GSH content or caspase-3
activity; however, in hearts given TPEN, there was a significant
reduction in Cu/Zn-SOD activity compared with control I/R hearts
(Fig. 5(d); P< 0·05). TPEN also markedly reduced the number of
ventricular arrhythmias occurring as single VPB, salvos and VT
(Fig. 6(a)) and significantly reduced the incidence of VT but had
no effect on the development of VF (online Supplementary Table
S3). Before coronary occlusion, TPEN induced a rise in CPP (Fig.
6(b)), which was maintained throughout the period of regional
ischaemia (Fig. 6(c)). In contrast, neither the administration of
TPEN nor the induction of regional ischaemia significantly altered
HR in any of the isolated hearts (Fig. 6(d)).
Acute in vitro zinc depletion and vascular function
TPEN (10µM) significantly reduced the contractile response to
U46619, which was used to pre-contract vessel rings to determine
vasodilator responses (Table 2). Similarly, TPEN induced a sig-
nificant shift to the right of the dose–response curves and a reduction
in maximum relaxant responses to both MCh (endothelium-
dependent) and SNP (endothelium-independent) (Fig. 7(a) and (b)
and Table 2). In contrast, DTPA (extracellular Zn chelator; 10µM) did
not affect either the contractile response toU46619 or the vasodilator
responses to MCh or SNP (Fig. 7(c) and (d) and Table 2).
Discussion
The majority of studies determining the value of Zn in cardio-
and vasculo-protection have focused on exogenous Zn
supplementation, rather than considering the importance of
endogenous Zn in maintaining a healthy and resilient cardio-
vascular system. This study aimed to determine the effects of
endogenous Zn depletion, induced by two distinct methods
(in vivo dietary deficiency and in vitro removal of intracellular
Zn) to demonstrate the importance of maintaining adequate Zn
levels to protect the heart in the event of an acute myocardial
infarction and also to determine the most physiologically rele-
vant experimental model for further study.
Dietary deficiency v. acute depletion effects on zinc and
blood/tissue marker status
Induction of dietary Zn deficiency for 14 d led to a slowed
increase in BW resulting from the reduced food intake, leading to
lower fat accumulation (reduced WAT:BW ratio) and an increase
in heart:BW ratio. In ZD rats, plasma Zn was markedly reduced
(by >50%), while other blood markers that could influence
infarct size (Cu2+ and Ca2+ , lactate and creatine kinase levels;
online Supplementary Table S1) were unaffected; thus, any dif-
ference between the ZD rats and the ZA/PF rats can be attributed
to alterations in plasma Zn status alone. However, dietary Zn
deficiency did not significantly alter cardiac tissue levels of Zn
which, although perhaps surprising, agrees with other stu-
dies(16,17). Notwithstanding this, it is worthy of note that the tissue
Zn levels reported here represent protein-bound Zn, as Zn levels
were undetectable in deproteinated samples (lower detection
limit of the assay was 0·5nmol/sample), indicating that there was
no detectable free Zn to participate in Zn-dependent cellular
process such as glutathione synthesis (see below).
The mechanism by which cardiac tissue levels of Zn are
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Fig. 2. Impact of a zinc-deficient (ZD) diet on myocardial infarct size (as a percentage of area at risk; AAR) (a), caspase-3 activity (b), glutathione (GSH) content (c)
and superoxide dismutase (SOD)-1 (copper/zinc SOD) activity (d) in isolated hearts subjected to a 30min acute regional myocardial ischaemia and 2h reperfusion.
Values are means (n 10 per group), with standard errors of the mean represented by vertical bars. * P< 0·05 ZD compared with pair-fed (PF) controls. † P< 0·05 PF
compared with zinc-adequate (ZA) controls.
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likely linked to the tight control systems that maintain intracel-
lular Zn homoeostasis. The homoeostatic mechanisms in the
cardiomyocyte are as yet poorly defined(31), but in most cells
intracellular Zn concentration is kept within a tight window by
two families of Zn transporters (ZnT and ZIP). ZnT promote
efflux from the cell, while ZIP increase intracellular Zn by
promoting transport into the cytoplasm (reviewed in Luizzi &
Cousins(32)). Additional control is provided by metallothio-
nein(33), which is largely a mechanism to protect the cell against
excessive increases in intracellular Zn. ZnT2 and ZnT5, along
with most of the ZIP transporters, are known to be expressed in
cardiac tissue(34), and in non-cardiac cells ZnT2 is markedly
down-regulated in response to Zn deficiency, while ZIP2 and
ZIP4 are up-regulated. If this is also the case in the cardio-
myocyte, it would result in reduced Zn efflux alongside
increased entry, which could explain the preservation of the Zn
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Fig. 3. Influence of a zinc-deficient (ZD, ) diet on arrhythmia count (a)
and changes in coronary perfusion pressure (CPP, b) and heart rate (c) before
and during the ischaemia–reperfusion protocol. Values are means (n 10 per
group), with standard errors of the mean represented by vertical bars. *P< 0·05
compared with pre-ischaemic ZD values. † P< 0·05 pair-fed (PF, )
compared with zinc-adequate (ZA, ) controls. VPB, ventricular
premature beat.
Table 1. Emax and pEC50 values for responses to vasoactive agents in
mesenteric arteries from zinc-adequate (ZA), zinc-deficient (ZD) and pair-
fed (PF) rats
(Mean values with their standard errors, n 10 per group)
Δ Tension (mN/mm) ZA PF ZD
U46619
Mean 2·68 2·41 2·99
SEM 0·59 0·39 0·56
Emax (%)
MCh
Mean 76·7 81·6 79·4
SEM 9·7 5·1 9·1
SNP
Mean 95·9 78·7 76·6
SEM 8·8 4·7 6·4
pECS0 (M)
U46619 6·48 6·46 6·51
MCh 7·39 7·51 7·27
SNP 7·45 7·69 7·81
Emax, maximal relaxation as a percentage of induced tone; pEC50, log of the half-
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Fig. 4. Responses of mesenteric arteries from zinc-adequate (ZA, ), pair-
fed (PF, ) and zinc-deficient (ZD, ) rats, pre-contracted with U46618
(EC80; concentration producing 80 % of the maximum response), to the
endothelium-dependent vasodilator methacholine (MCh; a) and the directly
acting vasodilator sodium nitroprusside (SNP; b). Values are means (n 10 per
group), with standard errors of the mean represented by vertical bars.
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In vitro acute Zn depletion, achieved by treating hearts with
TPEN, similarly did not alter the total tissue Zn content. While
alterations in Zn transporter activity may similarly explain pre-
served cardiac Zn levels in TPEN-treated hearts, we cannot rule
out the possibility that the effects of TPEN are due to the
removal of other cations (such as Ca2+ ). However, at the con-
centrations used in the present study, TPEN has a much higher
affinity for Zn.
Zinc and ischaemia–reperfusion injury
While there are substantial data to support the notion that
supplementation with exogenous Zn in the setting of I/R is
cardioprotective, relatively little is known about the importance
of endogenous Zn in the development of myocardial injury(5).
Endogenous Zn has been reported to be both cardioprotective,
by acting as an intracellular messenger that translates the sig-
nalling process in nitric oxide (NO)-mediated cardioprotec-
tion(35), and detrimental, through activation of extracellular
signal-regulated kinase/glycogen synthase kinase β (ERK/
GSK3β) to trigger cardiomyocyte death(36) in I/R. However,
very few studies have determined whether depletion of endo-
genous Zn levels can influence the outcome of I/R. In this
study, we have shown that both acute dietary Zn deficiency and
acute in vitro Zn depletion increase infarct size following I/R
injury in isolated hearts, which is consistent with the notion that
Zn is cardioprotective. Since endogenous Zn is known to play
an important role in maintaining redox status within tissues(37),
we also determined whether Zn deficiency upsets the redox
balance in cardiac tissue as a possible mechanism for the
increase in tissue injury.
In the case of dietary Zn deficiency, there was a marked
reduction in total myocardial GSH levels of ZD rats compared
with both ZA and PF rats. This provides a plausible explanation
for the increase in infarct size since GSH is a powerful anti-
oxidant that prevents reactive oxygen species (ROS)-induced
tissue injury(38), and reduced GSH levels have been associated






















































































































Fig. 5. Effect of the zinc chelator N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN, 10 µM) on myocardial infarct size (as a percentage of area at risk;
AAR) (a), cardiac tissue zinc content (b), glutathione (GSH) content (c) and superoxide dismutase (SOD)-1 (copper/zinc SOD) activity (d) and caspase-3 activity (e), in
isolated hearts subjected to 30min acute regional myocardial ischaemia and 2h reperfusion. Values are means (n 10 per group), with standard errors of the mean
represented by vertical bars. * P< 0·05 compared with vehicle controls. † P< 0·05 compared with sham controls. I/R, ischaemia–reperfusion.
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injury(39). Zn is an important co-factor in GSH synthesis as it
increases the expression of glutamate cysteine ligase (GCL), the
enzyme that catalyses GSH synthesis. Zn deficiency has been
shown to reduce GSH levels in other tissues and cells such as
liver(40,41), erythrocytes(42) and brain(43), but to our knowledge,
this is the first time the effect has been observed in cardiac
tissue. However, while dietary Zn-deficiency-induced GSH
deficit has been linked to increased cleavage of GCL(44)
resulting from activation of caspase-3(45), we did not see any
increase in caspase-3 activity in hearts from ZD rats. Interest-
ingly, hearts from PF rats exhibited higher caspase-3 activity,
which is surprising since energy restriction has been associated
with caspase-3 inactivation in the heart(45), albeit for longer (15–
35 weeks) and more severe (30% reduction in food intake)
energy restriction. Although Zn is similarly an important co-
factor for the cytosolic superoxide scavenging enzyme Cu/Zn-
SOD (SOD-1) which, when applied exogenously to the heart
upon reperfusion, is cardioprotective(46), we did not observe
any changes in SOD-1 activity that could explain the impact of
dietary Zn depletion on infarct size. However, this is consistent
with the finding that endogenous SOD-1 deficiency does not
influence the extent of reperfusion injury(47).
The only previous study of dietary Zn deficiency on myo-
cardial injury, performed in rats subjected to permanent and
sustained (48 h) coronary occlusion, showed that despite a
significant increase in cardiac lipid peroxide levels, there was
no effect on infarct size(16). However, because lethal injury as a
result of oxidative stress is induced upon reperfusion, and since
Zn deficiency is known to diminish the ability of cells to
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Fig. 6. Influence of N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN, , 10 µM) on arrhythmia count (a), the incidence of ventricular tachycardia (VT)
and ventricular fibrillation (b) and changes in coronary perfusion pressure (CPP, c) and heart rate (d) before and during the ischaemia–reperfusion protocol. Values are
means (n 10 per group), with standard errors of the mean represented by vertical bars. * P< 0·05 v. vehicle ( ) control. VPB, ventricular premature beat.
Table 2. Emax and pEC50 values for responses to vasoactive agents in mesenteric arteries from zinc-adequate, zinc-deficient and pair-fed rats
(Mean values with their standard errors, n 10 per group)
Δ Tension (mN/mm) Emax (%)
U44619 MCh SNP pEC50 (M)
Mean SEM Mean SEM Mean SEM MCh SNP
TPEN (1 µM) Vehicle – 91·6 2·2 95·2 0·9 7·03 7·27
TPEN – 91·7 1·8 94·1 1·1 6·94 7·56
TPEN (10 µM) Vehicle 3·24 0·32 86·6 2·1 74·5 4·2 7·04 7·04
TPEN 1·46* 0·11 68·2* 3·4 52·6* 8·7 6·52* 6·54*
DTPA (10 µM) Vehicle 5·84 0·83 72·4 6·9 87·8 3·5 7·01 7·18
DTPA 5·87 0·90 80·1 6·2 86·4 4·6 6·86 7·32
Emax, maximal relaxation as a percentage of induced tone; pEC50, log of the half-maximal concentration; MCh, metacholine; SNP, sodium nitroprusside; TPEN, N,N,N′,N′-tetrakis(2-
pyridinylmethyl)-1,2-ethanediamine; DTPA, 2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid.
* P< 0·05 v. vehicle.
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the concept that endogenous Zn is important in moderating the
extent of reperfusion, rather than ischaemic, injury. Indeed, our
results with dietary Zn depletion are supported by the findings
that contractile recovery post I/R is significantly impaired in
hearts from ZD rats(17).
To correct for any influence of reduced food intake caused by
cyclical feeding behaviour induced by the ZD diet, we included PF
animals as controls and found that pair feeding per se had no
significant effect on the extent of I/R injury compared with ZA rats.
Short-term (7–14d) energy restriction has been associated with a
cardioprotective effect in terms of post I/R recovery of cardiac
function(48) and a reduction in infarct size following permanent
coronary occlusion(49). Therefore, since there was no expansion of
infarct size in the PF hearts, we can tentatively conclude that the
worsening of I/R in the ZD rats is due to the lack of Zn rather than
to reduced food, and therefore energy, intake.
Although in vitro endogenous Zn depletion with TPEN
similarly resulted in an increase in infarct size, unlike dietary
deficiency this was associated solely with a reduction in Cu/Zn-
SOD activity since glutathione levels were preserved and there
was no evidence of caspase-3 activation. Although, as men-
tioned above, endogenous SOD-1 has been shown to be an
unlikely contributor to post-reperfusion tissue preservation, it is
not the only Zn-dependent isoform of SOD. Extracellular SOD
(SOD-3), which is concentrated in the extracellular space
between smooth muscle cells and the endothelium of the vas-
cular wall, plays a critical role in regulating the vascular redox
state(50) and evidence suggests that it is the interstitial levels of
SOD-3, rather than SOD-1, that confer protection against I/R
injury(51). Since our assay measures total Cu/Zn-SOD (i.e.
SOD-1 and SOD-3), the increase in infarct size is most likely due
to an inhibition of SOD-3, rather than SOD-1 activity.
As with dietary Zn deficiency, very few studies have
employed TPEN to determine the effects of acute endogenous
Zn depletion on myocardial infarct size. While the expansion of
infarct size in the presence of TPEN is compatible with
numerous studies showing that Zn supplementation is cardio-
protective (reviewed in Xu & Zhou(5)), the only other study to
explore the role of endogenous Zn in infarct size using TPEN
showed it to be cardioprotective when applied throughout
reperfusion(36). While this is difficult to reconcile with the pre-
sent data, it is most likely explained by the differences in
experimental protocols (i.e. pre-ischaemia v. post-reperfusion
administration) but certainly requires further investigation.
Zinc and ventricular arrhythmias
In contrast to the effects on myocardial infarct size, dietary Zn
deficiency did not have any worsening effect on the severity of
ventricular arrhythmias but rather, when compared with ZA
hearts, ZD hearts had a lower total arrhythmia count during the
ischaemic period, predominantly due to a reduction in salvos,
although the incidence of the more severe arrhythmias (VT and
VF) was not changed. However, this effect is most likely
explained by the reduced energy intake, as opposed to Zn
depletion, in these animals as hearts from PF rats similarly
exhibited fewer arrhythmias. Indeed, energy restriction has
been shown to induce bradycardia, prolong QT- and QRS-
intervals and to reduce the arrhythmogenic response to adre-
naline through a reduction in β-adrenoceptor density and
binding(52). Although we did not see any difference in baseline
HR between ZA, ZD and PF hearts, these were measured in
isolated hearts without the influence of sympathetic tone and so
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Fig. 7. Effects of N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN (10 µM), ) (a and b) and the extracellular zinc chelator 2-[bis[2-[bis(carboxymethyl)
amino]ethyl]amino]acetic acid (DTPA) (10 µM) ( ) (c and d) on responses of mesenteric arteries to the endothelium-dependent vasodilator methacholine (MCh) and
the directly acting vasodilator sodium nitroprusside (SNP). Values are means (n 10 per group), with their standard errors represented by vertical bars. * P< 0·05
compared with control.
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detected. TPEN, on the other hand, did exert a significant anti-
arrhythmic effect by reducing total arrhythmia count and the
incidence of VT during ischaemia. It is unlikely that this was
related to the reduction in SOD-1/3 activity since neither
superoxide generation nor superoxide scavenging has been
associated with a pro- or anti-arrhythmic effect (respectively)
in this model(53). However, other studies describing the anti-
arrhythmic effects that TPEN have ascribed these to inhibition
of NO accumulation(14) and activation of the sarcolemmal Na+/
Ca2+ exchanger to prevent Ca2+ overload(15).
Vascular effects of zinc depletion
Zn deficiency/depletion is associated with adverse effects on
both vascular smooth muscle(23) and endothelial(24) cells that
would be expected to result in abnormalities of blood vessel
function. Indeed, dietary Zn deficiency during fetal develop-
ment(21) and growth(22) results in elevated blood pressure, and
in adult hypertensive animals Zn deficiency exaggerates the
elevated blood pressure(54), effects that are believed to be a
consequence of increased oxidative stress resulting in endo-
thelial impairment and reduced availability of NO. However, in
normotensive adult animals subjected to dietary Zn deficiency,
the blood pressure remains unaffected and both endothelial NO
synthase and SOD-1 expression are normal(55). Although we
did not measure the arterial blood pressure in our dietary
intervention study, the lack of effect of Zn deficiency on
baseline CPP, which gives an indication of vascular tone in the
coronary resistance bed, and the normal responses to both and
endothelium-dependent (MCh) and -independent (SNP) vaso-
dilator in blood vessels isolated from the ZD rats is consistent
with the view that dietary Zn deficiency in normotensive adult
animals does not impair vascular function, despite the patho-
logical remodelling that has been demonstrated in previous
studies(20,23).
While the impact of acute in vitro Zn depletion has been
explored at the cellular level, very little has been done to
determine the functional consequence in isolated intact blood
vessels. Here we have shown that, in contrast to dietary inter-
vention, exposure of mesenteric arteries to TPEN impairs both
contractile and relaxant (endothelium dependent and inde-
pendent) responses, while the extra-cellular Zn chelator DTPA
does not. Thus, in light of the observed impact of TPEN on
cardiac SOD activity, the most likely cause of the reduced
endothelium-dependent responses is the inhibition of SOD-1
(cytosolic isoform), since DTPA would only remove the Zn that
would allow SOD-3 (located within the interstitial spaces) to
operate, whereas TPEN would reduce Zn availability for both
SOD-1 and SOD-3. This would also explain the reduced
response to SNP, which donates a NO moiety that is as sus-
ceptible to degradation by ROS as endogenously produced NO.
In relation to the attenuation of the contractile response seen
with TPEN, though as a chelator it has a higher affinity for Zn
than for other metals, it has been shown in other cell types to
impair intracellular Ca release from the sarcoplasmic reticu-
lum(56), albeit at much higher concentrations (50–500 µM) than
that used in the current study (10 µM).
Conclusions
The principal findings from these studies are that both acute
dietary Zn deficiency and acute in vitro Zn depletion worsen
the extent of myocardial injury resulting from I/R while para-
doxically protecting against severe ventricular arrhythmias. The
mechanisms by which these effects are achieved, however,
appear to differ. Dietary Zn deficiency results in a reduction in
total cardiac GSH content, which predisposes the heart tissue to
the widespread damaging effects of the oxidative stress induced
during post-IR, while the predominant system that is affected by
in vitro Zn depletion is the limited capacity to scavenge
superoxide. Similarly, while in vitro Zn depletion has a marked
effect on the ability of intact blood vessels to both contract and
relax, dietary Zn deficiency does not. Again this appears to be
related to the differing effects of the two interventions on SOD
activity. Taken together, these results have shown that dietary
insufficiency of Zn presents a potential risk factor for a worse
outcome following acute myocardial ischaemia, with the asso-
ciated increased morbidity and mortality. Moreover, our find-
ings with TPEN suggest that future studies into the role of Zn in
cardiovascular physiology and pathophysiology should be
carried out using a dietary intervention model, rather than an
in vitro simulation of endogenous Zn depletion, to avoid mis-
leading findings.
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